Trastuzumab adds to adjuvant chemotherapy for resected HER2-positive breast cancer.
Hudis
Clifford A
CA
Breast Cancer Medicine Service, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA. hudisc@mskcc.org